CC
STJ

CQS Cayman’s St Jude Medical STJ Stock Holding History

CQS Cayman’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44,500
Closed -$3.55M – 151
2016
Q3 		$3.55M Sell
44,500
-39,500
-47% -$3.19M 0.3% 61
2016
Q2 		$6.55M Buy
+84,000
New +$5.99M 0.58% 47

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CQS Cayman's STJ Position: Q4 2016 in Review

CQS Cayman sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 44,500 shares — an estimated $3.55M sold.

CQS Cayman first reported a position in STJ in Q2 2016 and held it in 2 quarters. The position peaked at $6.55M in Q2 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • CQS Cayman reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • CQS Cayman sold 44,500 St Jude Medical shares in Q4 2016, an estimated $3.55M.
  • CQS Cayman first reported a position in St Jude Medical in Q2 2016 and held it in 2 quarters.
  • CQS Cayman's St Jude Medical position peaked at $6.55M in Q2 2016.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on CQS Cayman's 13F filing for Q4 2016, filed 14 Feb 2017.